Table 5.
Cox regression analysis in patients with acute decompensated heart failure and acute kidney injury.
| Variables | HR | 95% CI | P |
|---|---|---|---|
| Age | 0.989 | 0.959–1.020 | 0.489 |
| Sex | 1.005 | 0.990–1.020 | 0.545 |
| Diabetes history | 1.798 | 0.498–6.489 | 0.370 |
| Myocardial infarction history | 1.775 | 0.091–14.407 | 0.705 |
| Heart failure history | 1.583 | 0.450–5.576 | 0.474 |
| Coronary heart disease | 1.193 | 0.338–4.208 | 0.783 |
| Hypertension | 2.347 | 0.620–5.891 | 0.202 |
| Cardiomyopathy | 0.473 | 0.084–2.653 | 0.395 |
| LVEF | 0.465 | 0.032–6.814 | 0.576 |
| NT-pro-BNP | 0.398 | 0.011–14.407 | 0.615 |
| Serum albumin | 0.726 | 0.276–1.911 | 0.517 |
| Scr | 0.443 | 0.133–1.471 | 0.184 |
| eGFR | 2.745 | 0.822–6.657 | 0.113 |
| sNGAL | 2.815 | 0.954–6.851 | 0.075 |
| uNGAL | 2.941 | 1.527–7.088 | 0.034 |
| smiR-652-3p | 2.903 | 1.475–6.714 | 0.041 |
| umiR-652-3p | 3.418 | 1.889–7.969 | 0.013 |
HR, hazard ratio; CI, confidence interval; LVEF, left ventricular ejection fraction; NT-pro-BNP, N-terminal pro-brain natriuretic peptide; Scr, serum creatinine; eGFR, estimated glomerular filtration rate; sNGAL, serum neutrophil gelatinase-associated lipocalin; uNGAL, urinary neutrophil gelatinase-associated lipocalin; smiR-652-3p, serum microRNA-652-3p; umiR-652-3p, urinary microRNA-652-3p.